Brief: Enzyvant Therapeutics And Altavant Sciences Announce Merger
06/12/2022 15:37
Dec 6 (Reuters) - Enzyvant Therapeutics Inc:
* ENZYVANT THERAPEUTICS INC AND ALTAVANT SCIENCES INC, BOTH
WHOLLY
OWNED SUBSIDIARIES OF SUMITOVANT BIOPHARMA LTD, ANNOUNCE A
MERGER
* ENZYVANT THERAPEUTICS - FINANCIAL TERMS OF DEAL WERE NOT
DISCLOSED
* ENZYVANT THERAPEUTICS - COMBINED COMPANY RETAINS NAME
ENZYVANT
Source text for Eikon: ID:nGNX61TXDN
Further company coverage: 4506.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sumitomo Pharma
See all newsSumitomo Pharma America Announces First Patient Receives Treatment In Phase 1/2A Study For Investigational Therapy Dsp-3077 For Retinitis Pigmentosa
Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report)
Brief: Sumitomo Pharma - Gotham City Research's August 3 Report Contains Numerous Statements That Are Clearly Inconsistent With Facts
Brief: Gotham City Research Holds Short Positions In Sumitomo Chemical And Sumitomo Pharmaceutical
Table: Sumitomo Pharma -Q1 group results (IFRS)